Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients

Immune Tolerance Network (ITN) T1DAL Study Group

Research output: Contribution to journalArticlepeer-review

146 Scopus citations

Fingerprint

Dive into the research topics of 'Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients'. Together they form a unique fingerprint.

Medicine & Life Sciences